CASE OF THE WEEK
A 54 year old woman was diagnosed with left-sided breast cancer in October 2015.  She was treated with chemotherapeutic agents (CA) Adriamycin (cumulative dose of 400 mg/m2), cyclophosphamide and trastuzumab (Herceptin®). She also received ADO–trastuzumab emtansine (Kadcyla®) for a history of metastatic breast cancer previously receiving treatment with Herceptin®. 
News from Around the World
RAISING AWARENESS DURING HEART HEALTH MONTH
SCMR is requesting assistance from members to help raise awareness on the value of CMR during Heart Health month.
February 22, 2019
22ND SCIENTIFIC SESSIONS AWARDS
View this year's Scientific Sessions award recipients including the 2019 SCMR Gold Medal Award.
February 13, 2019
SCMR RECEIVES NIH FUNDING
SCMR has received an R13 Conference Grant Award to support the travel awards and mentoring programs at the annual scientific sessions.
January 20, 2019
Journal of Cardiovascular Magnetic resonance
RESEARCH: A cardiovascular magnetic resonance (CMR) safe metal braided catheter design for interventional CMR at 1.5 T: freedom from radiofrequency induced heating and preserved mechanical performance

Korel Yildirim,, et al.

Published on: 7 March 2019

Corporate Support

Mailing Address
19 Mantua Rd
Mt. Royal, NJ 08061
Contact Us
856.423.8955
hq@scmr.org
Connect With Us